Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2583-2586

  Yap, George ^a   Cheever, Allen ^a   Caspar, Patricia ^a   Jankovic, Dragana ^a   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; DELAYED HYPERSENSITIVITY; DOWN REGULATION; GRANULOMATOUS INFLAMMATION; IMMUNE RESPONSE; INFECTION; LIVER DISEASE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE ACTIVATION;

EID: 0030968979     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2583-2586.1997     Document Type: Article

References (35)

1. Amiri, P., M. Haak-Frendscho, K. Robbins, J. H. MeKerrow, T. Stewart, and P. Jardieu. 1994. Anti-immunoglobuiln-E treatment decreases worm burden and egg production in Schitosoma mansoni-infected normal and interferon gamma knockout mice. J. Exp. Med. 180:43-51.
2. Bloom, B, R., P. Salgame, and B. Diamond. 1992. Revisiting and revising suppressor T cells. Immunnol. Today 13:131-136.
3. Borojevic, R. 1992. Experimental murine schistosomiasis mansoni: establishment of the chronic phase of disease. Mem. Inst. Owaldo Cruz 87:-171-174.
4. Boros, D., and K. Warren. 1970. Delayed hypersensitivity type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132:488-507.
5. Boros, D. L., R. P. Pelley, and K. S. Warren. 1975. Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J. Immunol. 114:1437-1441.
6. Cheever, A. W. 1986. The intensity of experimental schistosome infections modulates hepatic pathology. Am. J. Trop. Med. Hyg. 35:124-133.
7. Chensue, S. W., D. L. Boros, and K. S. Warren. 1981. Modulation of granulomatous hypersensitivity. 11. Participation of Ly 1 + and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni infected mice. J. Immunol. 127:363-367.
8. Chensue, S. W., K. S. Warmington, S. D. Hershey, P. D. Terebuh, M. Othman, and S. L. Kunkel. 1993. Envolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated hy CD8+ T cells in vivo. J Immunol. 151:1391-1400.
9. Colley, D. 1990. Occurrence and uses of idiotypes in parasitic diseases, p. 71. In J. Cerny and J. Hiernaux. (ed.), Idiotypic network and disease. American Society for Microbiology. Washington, D.C.
10. Colley, D. G. 1976. Adoptive suppression ol granuloma formation. J. Exp. Med. 143:696-700.
11. Czaja, M. J., K. R. Weiner, S. Tukohashi, M. A. Giambrone, P. H. van der Meide, M. Schellekens, L. Biempica, and M. A. Zern. 1989. γ-Interferon treatment inhibits collagen deposition in murine schislosomiasis. Hepatology 10:795-899.
12. Dation. D. K., S. Pitts-Meek, S. Keshav, J. S. Figari, A. Bradley, and T. A. Stewart. 1493. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739-1742.
13. Domingo, E. O., and K. S. Warren. 1968. Endogenous desensitization: changing host granulomatous response to schistosome eggs at different stages of infection with Schistosoma mansoni. Am. J. Pathol. 52:360-377.
14. Fung-Leung, W., M. W. Schilham, A. Rahemtulla, T. M. Kundig, M. Vollenweider, J. Potter, W. van Ewijk, and T. W. Mak. 1991. CD8 is needed for development of cytotoxic T cells but noy helper T cells. Cell 65:443-440.
15. Gajewski, T. F., and F. W. Fitch. 1988. Anti-proliferative effect of IFN-gamma in immune regulation. 1. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245-4252.
16. Henderson, G. S., X. Lu, T. L. McCurley, and D. G, Colley. 1992. In vivo molecular analysis of lymphokines involved in the murine immune response during schistosoma mansoni infection. II. Quantitation of IL-4 mRNA. IFN-gamma mRNA. and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes and spleen during the course of modulation. J. Immunol. 148:2261-2269.
17. Inoue, T., Y. Asano, S. Matsuoka, M. Furutani-Seiki, S. Aizawa, H. Nishimura, T. Shirai, and T. Tara. 1993. Distinction of mouse CD8+ suppressor T cell clones from cytotoxic T cell clones by cytokine production. J. Immunol. 150:2121-2128.
18. Jankovic, D., M. Kullberg, G. Yap, M. Epstein, A. Cheever, and A. Sher. 1996. B cell deficient mice exposed to Schistosoma mansoni develop exacerbated egg pathology which fails to down-modulate during chronic infection. FASRB. J. 10:1995.
19. Koh, D., W. Fung Leung, A. Ho, D. Gray, H. Acha-Orbea, and T, W. Mak. Loss mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. 1992. Science 256:1210-1212.
20. Koller, B. H., P. Marrack, J. W. Kappler, and O. Smithies. 1990. Normal development of mice deficient in β2M, MHC class I proteins and CD8+ T cells. Science 248:1227-1231.
21. Lammie, K J., S. M. Phillips, G. P. Linette, A. I. Michael, and A. G. Bentley. 1986. In vitro granuloma formation using defined antigenic nidi. Ann. N. Y. Acad. Sci. 465:340-350.
22. Litt, M. 1996. Studies in experimental eosinophilia. V. Eosinophils in lymph nodes of guinea pigs following primary antigenic stimulation. Am. J. Pathol. 42:520-532.
23. Ljunggren, H. G., R. Glas, J. K. Sanberg, and K. Karre, 1996. Reactivity and specificity of CD8+ T cells in mice with defects in the MHC class I antigen-processing pathway, Immunol. Rev. 151:123-148.
24. Lukacs, N. W., and D. L. Boros. 1993. Lymphokine regulation of granuloma formation in murine schistosomiasis mansni. Clin. Immunol. Immuno-pathol. 68:57-63.
25. Pearce, E. J., P. Caspar, J. M. Grzych, F. A. Lewis, and A. Sher. Downregulation regulation of Th1 cytokine production accamipanies induction of Th2 responses by a helminth, Schistosoma mansoni. 1991. J. Exp. Med. 173:159-166.
26. Pedras-Vasconcelos, J., and E. J. Pearce, 1996. Type 1 CD8+ T cell responses during infection with the helminth Sehistosoma mansoni. J. Immunol. 157:3046-3053.
27. Pernis, A., S. Gupta, K. J. Gollob, K. Garfein, R. L. Coffman, C. Schindler, and P. Rothman, 1995. Lack of interferon gumma receptor beta chain and the prevention of interferon gamma signalling in TH1 cells. Science 269:245-247.
28. Ragheb, S., and D. L. Boros. 1989. Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J. Immunol. 142:3239-3240.
29. Sher, A., R. L. Coffman, S. Hieny, P. Scott, and A. W. Cheever. 1900. Interleukin 5 is required for the blood and tissue cosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. USA 87:61-65.
30. Van Kaer, L., P. G. Ashton-Rickardt, H. L. Ploegh, and S. Tonegawa. 1901 TAP 1 mutant mice are deficient in antigen presentation, surface class 1 molecules and CD4-CDS+ T cells. Cell 71:1205-1214.
31. Vella, A. T., and E. J. Pearce. 1992. CD4 + Th2 response induced by Schistosoma mansoni eggs develops rapidly through an early transient Th0-like stage. J. Immunol. 148:2283-2290.
32. Warren, K. S., E. O. Domingo, and R. B. T. Cowan. 1967. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am. J. Pathol. 51:735-756.
33. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12 based vaccination method for preventing fibrosis induced by schistosomo infection. Nature 376:504-506.
34. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430-1440.
35. Wynn, T. A., I. Eltoum, I. P. Oswald, A. Cheever, and A. Sher, 1994. Interleukin 12 regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1551-1561.